Otezla

Pharma

Trial results enhance BMS bid for Sotyktu in psoriatic arthritis

At the American Academy of Dermatology's annual meeting, BMS revealed data from one of two successful phase 3 trials of Sotyktu in psoriatic arthritis.

Kevin Dunleavy Mar 10, 2025 8:38am

Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says

Dec 23, 2024 11:25am

Amgen tipped to keep Otezla market share in BMS' Sotyktu fight

Sep 5, 2023 7:25am

Arcutis launches branded Zoryve ad for a 'Cream That Can'

Aug 29, 2023 10:00am

A frame from Amgens Live In The Moment Otezla ad

Amgen runs lighthearted Otezla ad as psoriasis market heats up

Aug 15, 2023 7:55am

AbbVie's Skyrizi tops Amgen's Otezla in head-to-head study

Jul 26, 2023 10:45am